After many slow years in the 2000s, the pharma and biotech sectors are now in the midst of a remarkable period, where the number of new drug approvals has risen sharply, and many genuinely innovative drugs are reaching the market. Ireland is one of the leading locations for the pharmaceutical industry in Europe. For a country of just 4.6 million people, Ireland punches well above its weight and is undoubtedly a world player in pharmaceutical production.
If you have watched the Pharmaceutical industry rally in the past few years, you now have an opportunity to make up for missing out. We are proud to introduce a new investment product offering: Alpha Pharmaceutical Bond. This is a unique investment in the sense that it offers a specific opportunity for superior returns, while controlling the risk.
- 4 Year Term
- 80% Capital Protection
- 135% Participation
- Underlying Stocks: Pfizer Inc, Novartis AG and GlaxoSmithKline PLC.
We don’t expect you to be convinced yet, so we designed a presentation. Contact us now for more information.